| Literature DB >> 27582592 |
Zahra Naseri1, Mohammad Yousef Alikhani2, Seyed Hamid Hashemi1, Farideh Kamarehei2, Mohammad Reza Arabestani2.
Abstract
Brucellosis is a widespread zoonotic disease causing considerable economic and public health problems. Despite animal vaccination, brucellosis remains endemic in some areas such as Iran, especially in the western Iranian province of Hamadan. We sought to detect some of the most common virulence-associated genes in Brucella isolated from human blood cultures to determine the prevalence of some virulence genes among Brucella isolates. Fifty-seven isolates were studied from patients with a clinical diagnosis of brucellosis who referred to the Infectious Diseases Ward of Sina Hospital in Hamadan Province, Iran, between April 2013 and July 2014. Blood samples were collected for the diagnosis of brucellosis using the BACTEC blood culture system. All of these isolates were confirmed by the bcsp31 Brucella-specific gene. We detected 11 virulence-associated genes of Brucella, namely cβg, virB, znuA, ure, bvfA, omp25, omp31, wbkA, mviN, manA, and manB, which are important for the pathogenesis of this bacterium in the intracellular environment by multiplex PCR. Totally, 149 patients with a clinical diagnosis of brucellosis were enrolled in this study. Fifty-seven (38.3%) patients had positive blood cultures. On biochemical and molecular testing, all of the isolates were Brucella melitensis. Ten of the virulence genes were detected among all of the 57 isolates, but the bvf gene was detected in 53 (93%) isolates. The high prevalence of virulence-associated genes among the Brucella isolates detected in Hamadan Province, Iran, underscores the pathogenicity of this bacterium in this region.Entities:
Keywords: Brucella melitensis; Brucellin; Iran; Virulence factors
Year: 2016 PMID: 27582592 PMCID: PMC4967487
Source DB: PubMed Journal: Iran J Med Sci ISSN: 0253-0716
Sequence of the primers and the amplicon sizes of the bcsp31 gene for Brucellamelitensis detection
| Gene | Primer Sequences (5’ 3’) | Amplicon Size | References |
|---|---|---|---|
| BM: AATCGCGTCCTTGCTGGTCTGA | 731 bp | 15 |
Sequence of the primers and the amplicon sizes for the detection of 11 virulence-associated Brucellamelitensis
| Genes | Primer Sequences (5’ 3’) | Amplicon Sizes | References |
|---|---|---|---|
| F: GAATTCGCCAATGAGGAAAA | 575 bp | 16 | |
| F: GCAGATCAACCTGCTCATCA | 344 bp | 16 | |
| F: TCGATCCAGAAACCCAGTTC | 271 bp | 16 | |
| F: GGCTGGTTCGAGAATATCCA | 228 bp | 16 | |
| F: GAGCGCTTAGGAATGCTGAT | 309 bp | 16 | |
| F: CGTACCTCACGGCTGGTATT | 188 bp | 16 | |
| F: GCTGCTCCTGTTGACACCTT | 257 bp | 16 | |
| F: CTGGGTCCGAGCATGTTTAT | 465 bp | 16 | |
| F: CCCTTCGTCGATGTGCTGA | 1282 bp | 17 | |
| F: CGCTGATCTATAATTAAGGCTA | 881 bp | 17 | |
| F: GCTTGCCCTTGAATTCCTTTGTGG | 2100 bp | 17 |
Positive and negative controls of the polymerase chain reaction assay
| The controls | Strains | ATCC |
|---|---|---|
| Positive control | Vaccine strain | |
| Negative control | 12386 | |
| Negative control | 29212 | |
| Negative control | 25922 | |
| Negative control | 25423 | |
| Negative control | Clinical isolate | |
| Negative control | Clinical isolate | |
| Negative control | Clinical isolate | |
| Negative control | Clinical |
Characteristics of the patients who participated in this study
| Characteristics | Number | Percent |
|---|---|---|
| Sex | ||
| Male | 27 | 47 |
| Female | 23 | 40 |
| Age (mean±SD) | Mean=41.1±17.2 years | |
| Education | ||
| Under diploma | 109 | 73.2 |
| Diploma | 32 | 21.5 |
| Bachelor’s degree | 6 | 4 |
| Master’s degree | 1 | 0.7 |
| Doctorate | 1 | 0.7 |
| Living | ||
| Rural | 83 | 56 |
| Urban | 66 | 44 |
| Occupations | ||
| Farmer | 68 | 45.6 |
| Housewife | 39 | 26.2 |
| Employed | 28 | 18.8 |
| Administrative jobs | 8 | 5.4 |
| Butcher | 4 | 2.7 |
| Veterinarian | 1 | 0.67 |
| Clinical picture | ||
| Fever | 122 | 81.9 |
| Arthralgia | 69 | 46.3 |
| Chills | 240 | 51.2 |
| Headache | 94 | 61.3 |
| Sweating | 112 | 75.2 |
| Anorexia | 110 | 73.8 |
| Low back pain | 102 | 68.5 |
| Weight loss | 112 | 75.2 |
| Myalgia | 132 | 88.6 |
| Arthritis | 17 | 11.4 |
| Hepatomegaly | 7 | 4.7 |
| Orchitis (males) | 20 | 13.4 |
| Meningismus | 1 | 0.7 |
| Splenomegaly | 2 | 1.3 |
| Lymphadenopathy | 4 | 2.7 |
| Spondylitis | 45 | 30.2 |
| Sacroiliitis | 67 | 45 |
Figure 1Gel electrophoresis for the results of the polymerase chain reaction (PCR) amplification of the 731-bp fragment using the bcsp31 gene for Brucella melitensis. Lanes L to 4: 100-bp DNA ladder; lane 1: Brucella melitensis Rev1 and vaccine strain (positive control); and lanes 2, 3, and 4: specimens whose results were positive by PCR.
Figure 2Gel electrophoresis for the results of the polymerase chain reaction amplification of the specimens whose results were positive for virB (881bp), cbg (575bp), znuA (465bp), wbkA (309bp), mviN (344bp), manA (271bp), manB (228bp), and omp25(188bp). Lane R1 (multiplex 1) contains virB (881bp), cbg (575bp), znuA (465bp), wbkA (309bp), omp31 (257bp), and fragment using the primer pair 16S rRNA. Lane L: 100-bp DNA ladder. Lane R2 (multiplex 2) contains mviN (344bp), manA (271bp), manB (228bp), and omp25 (188bp).
Figure 3Gel electrophoresis for the results of the polymerase chain reaction amplification of the ure and bvfA genes. Lanes 1 to 3: specimens whose results were positive for the ure gene (2100 bp); lane L: 1-kb DNA ladder; and lane 4: specimens whose results were positive for the bvfA gene (1282 bp).